Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy

NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first...

LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply

Cision PR Newswire

MINISFORUM Launches MS-S1 MAX-P495 with 192GB Unified Memory, Expanding Its Local AI Computing Strategy

SHENZHEN, China, Oct. 8, 2026 /PRNewswire/ -- As Artificial Intelligence (AI) evolves toward Super...
Cision PR Newswire

Dongpeng Highlights Sustainable Procurement at UN Global Compact Leaders Summit

Supplier capability building and circular materials connect sustainability requirements with opportunities for collaboration ...
Cision PR Newswire

Lufax Announces Poll Results of Extraordinary General Meeting

SHANGHAI, Oct. 8, 2026 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE:...
Cision PR Newswire

Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data provider

Sydney-based...

AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech

MACAO, May 31, 2026 /PRNewswire/ -- The BEYOND Expo 2026 has shown what the future looks like as it delivers on its mission of 'Empowering...

Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders

SHANGHAI, May 31, 2026 /PRNewswire/ -- The 28th Shanghai International Film Festival (SIFF) has officially unveiled the competition selections for the 2026 Golden Goblet...

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

CHENGDU,...

Cyient Enters Agreement to Acquire TAO Digital

Acquisition enhances Cyient's offering portfolio with AI-native data and lifecycle engineering capabilities to drive data-readiness & digital transformation for its customers HYDERABAD, India,...
1...342343344...4,424Page 343 of 4,424